Decks cleared for import of Bharat Biotech’s Covaxin, Russia’s Sputnik V into Brazil
The Hindu
According to Anvisa’s approval, Brazil is expected to receive four million doses of Covaxin initially
Brazil has cleared the proposal to import Bharat Biotech’s COVID-19 vaccine, Covaxin, into the South American country. National Health Surveillance Agency of Brazil — Anvisa — had earlier denied permission to import Covaxin after authorities found that the Indian plant in which the jab was being made did not meet the Good Manufacturing Practice (GMP) requirements. The Brazilian health regulator also approved another proposal to import Russia’s Sputnik V vaccine into that country.More Related News